Identifying and Developing
Breakthrough Medicines

Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. We leverage over 100 years of life science leadership to accelerate our clinical development program and are driven by the promise of developing life-changing oncology therapies on our path to become a leading biotech/pharmaceutical company.

Bexion Pharmaceuticals
Corporate Video

Bexion Milestones

Making Significant Progress

Bexion Media

PRESS RELEASE

Bexion Pharmaceuticals, Inc. Receives Rare Pediatric Disease Designation
September 30, 2020

FOR IMMEDIATE RELEASE [Covington, KY] September 30, 2020 Bexion Pharmaceuticals, Inc., a clinical stage biotechnology company focused on developing innovative cures for cancer, announced that the Federal Drug Administration (FDA) has granted the company’s request for rare pediatric disease designation for BXQ-350, Bexion’s lead therapeutic, for the treatment of diffuse intrinsic pontine glioma (DIPG) and […]

All Press

Cincinnati Enquirer: 8 Cincinnati biotech companies with big steps to watch in 2020
January 1, 2020